We are live on ! Find out more
CPV

Canaan Partners VII Portfolio holdings

AUM $32.3M
1-Year Est. Return 154.97%
This Fund
S&P 500
This Quarter Est. Return
+37.21%
1 Year Est. Return
+154.97%
3 Year Est. Return
-20.69%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.8M
AUM Growth
-$30.2M
Cap. Flow
-$66.1M
Cap. Flow %
-66.92%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
HAPN
Happen Inc
HAPN
+$62.3M
2
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$3.13M
3
TLRA
Telaria, Inc.
TLRA
+$687K

Sector Composition

Rank Sector Weight
1 Financials 87.17%
2 Communication Services 12.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAPN
1
Happen Inc
HAPN
$2.07B
$86.1M 87.17%
2,786,735
-2,400,000
-46% -$62.3M
TLRA
2
DELISTED
Telaria, Inc.
TLRA
$12.7M 12.83%
7,410,400
-389,597
-5% -$687K
MRNS
3
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-615,350
Closed -$3.13M

Similar funds

A
Aetna Hartford, Connecticut $35.3M AUM 7.55% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
SAC
SPQ Asia Capital Hong Kong $37.7M AUM 121.14% 1-Year Est. Return
MIGAR
Madison International Global Alpha Realty New York $25.9M AUM
CWM
Concert Wealth Management San Jose, California $24.7M AUM 14.91% 1-Year Est. Return
TCM
Trishield Capital Management New York $40.3M AUM
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
TAM
Target Asset Management Singapore $21.4M AUM 66.83% 1-Year Est. Return

Canaan Partners VII's Q3 2016 Portfolio in Review

As of Q3 2016, Canaan Partners VII held 3 positions worth $98.8M, down 23% from $129M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners VII withdrew a net $66.1M in Q3 2016, closing 1 position and reducing 2 holdings. Its most notable exit was Marinus Pharmaceuticals, Inc, an estimated $3.13M position sold in full.

By sector, the portfolio is most concentrated in Financials at 87% of assets, up from 86% a quarter earlier, followed by Communication Services.

  • Canaan Partners VII's biggest Q3 2016 reduction was Happen Inc, cutting an estimated $62.3M.
  • Canaan Partners VII fully exited Marinus Pharmaceuticals, Inc in Q3 2016, selling an estimated $3.13M.
  • Canaan Partners VII's ten largest holdings make up 100% of its $98.8M portfolio in Q3 2016.
  • Canaan Partners VII opened 0 new positions and closed 1 in Q3 2016.
  • Canaan Partners VII's portfolio value fell 23% quarter-over-quarter to $98.8M.

Based on Canaan Partners VII's 13F filing for Q3 2016, filed 7 Oct 2016.